Ranking
Cheapest Tirzepatide Programs
The cheapest tirzepatide program is the one with the lowest recurring cost after every mandatory fee, not the lowest advertised headline. Several providers advertise lower monthly figures than the ranked leaders here, but do not confirm whether membership, consultation, or shipping charges are included — so those prices are shown separately and are not treated as comparable.
Key takeaways
- The lowest advertised price and the lowest actual cost are frequently different figures.
- Only records with confirmed fee inclusion are ranked; advertised-only prices sit in a separate table.
- Introductory first-month pricing is excluded from ranking because it is not the recurring cost.
- Dose increases can change cost at some providers — that field is unverified for most.
- Verify the recurring price and all fees on the provider's own checkout before enrolling.
| Criterion | Lowest computed recurring cost |
|---|---|
| Records reviewed | 29 |
| Eligible | 7 |
| Excluded | 22 |
| Ordering | Computed cost only — no editorial score |
| Methodology | v1.0 |
| Publisher relationship with providers | NexLife — disclosed commercial partner (affiliate/referral, since 2026-09-04), labeled where it appears; not an input to the ordering. No other provider has any relationship |
Which providers rank highest?
| # | Provider | Effective $/mo | Basis | Mandatory fees | Price verified |
|---|---|---|---|---|---|
| 1 | TRYM Health | $125 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No hidden membership/shipping fees advertised | 2026-07-20 |
| 2 | Trimi | $125 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No membership fee (stated); visit, prescription, clinician support and | 2026-09-04 |
| 3 | NexLife | $139 | complete published commitment ladder for the standard injection: medication included, no separate membership or shipping fee | No separate membership fee; consultations and expedited shipping adver | 2026-09-04 |
| 4 | Yucca Health | $225 | complete published commitment ladder (monthly, 3- and 6-month; no 12-month tier) for the standard injection: medication included, no separate membership fee | None reported; consultation, injection kit and 2-day shipping stated a | 2026-09-04 |
| 5 | Fridays | $240 | advertised monthly rate with medication included and no separate membership fee | Generally advertised as all-inclusive | 2026-07-20 |
| 6 | Mochi Health | $278 | effective recurring cost: medication plus every mandatory fee, computed from the captured components | Membership $39 first month, then $79/month; shipping advertised includ | 2026-07-20 |
| 7 | Eden | $298 | effective recurring cost: medication plus every mandatory fee, computed from the captured components | Membership separate | 2026-07-20 |
Why is the lowest advertised price not the cheapest program?
Because an advertised monthly figure often covers medication only. Membership fees, consultation charges, and shipping are billed separately and can add substantially to the real monthly outlay. A program advertising $99 with a $79 monthly membership costs more than one advertising $139 with everything included.
This is why the ranking above uses computed recurring cost and quarantines advertised-only figures into their own table. Comparing an all-in price against a medication-only price is not a comparison.
Is the cheapest tirzepatide program a good idea?
Cheap is only meaningful if the treatment continues. A program priced low enough to be sustainable over years beats one that is marginally cheaper but comes with terms you cannot leave, or a surcharge that lands when your dose increases.
The failure mode this ranking cannot protect against is a low price attached to an unverified pharmacy. Cost transparency and product quality are different things, and only the first is measurable from outside.
What was the sample, and what was excluded?
Sample: 29 provider records reviewed, 7 eligible for this category, 22 excluded. Methodology v1.0; each record carries its own price-verification date.
| Provider | Reason for exclusion |
|---|---|
| OrderlyMeds | Advertised as a “from” starting price, not a recurring all-in cost |
| Henry Meds | Price stated in free text that cannot be normalised |
| Ivím Health | Price stated in free text that cannot be normalised |
| Amble | Price stated in free text that cannot be normalised |
| Lavender Sky Health | Advertised as a “from” starting price, not a recurring all-in cost |
| Fifty 410 | Advertised as a “from” starting price, not a recurring all-in cost |
| ShedRx / SHED | Advertised as a “from” starting price, not a recurring all-in cost |
| Remedy Meds | Mandatory-fee inclusion not confirmed in the captured source |
| Willow | Advertised as a “from” starting price, not a recurring all-in cost |
| GobyMeds | Price stated in free text that cannot be normalised |
| Zappy Health | Price stated in free text that cannot be normalised |
| SlimDownRx | Price stated in free text that cannot be normalised |
| Valhalla Vitality | Price stated in free text that cannot be normalised |
| Hims & Hers | Advertised figure covers medication only; mandatory care or membership fees billed separately |
| Ro Body | Price stated in free text that cannot be normalised |
| WeightWatchers Clinic | Advertised figure covers medication only; mandatory care or membership fees billed separately |
| Noom Med | Price stated in free text that cannot be normalised |
| LifeMD | Advertised as a “from” starting price, not a recurring all-in cost |
| Found | Advertised as a “from” starting price, not a recurring all-in cost |
| Embody | Advertised as a “from” starting price, not a recurring all-in cost |
| SnagRx | Advertised as a “from” starting price, not a recurring all-in cost |
| bmiMD | Advertised as a “from” starting price, not a recurring all-in cost |
How this ranking was produced
One shared eligibility function governs every ranking on this site: a record qualifies only when a recurring tirzepatide cost can be computed on a like-for-like basis, meaning mandatory fees are either included or confirmed absent. Ordering is by computed cost alone, with no editorial score.
The full methodology, including every exclusion rule, is published on the main provider ranking. Records excluded from this category are listed below with the reason each was excluded.
rel="sponsored" and the publisher may earn commissions from them. No other provider, pharmacy, or manufacturer named on this site has any financial, ownership, affiliate, referral, or sponsorship relationship with the publication. A commercial relationship cannot buy inclusion, position, or a favourable description: rankings are computed from published prices under a methodology published in advance — partners can lose under it, and NexLife sits third on committed cost behind TRYM Health and Trimi — and every featured placement is labeled where it appears.What does the market actually charge?
| Group | $/month |
|---|---|
| TRYM Health | 125 |
| Trimi | 125 |
| NexLife | 139 |
| Yucca Health | 225 |
| Fridays | 240 |
| Mochi Health | 278 |
| Eden | 298 |
| Component | Amount | Running total |
|---|---|---|
| Advertised medication price | $99 | $99 |
| Monthly membership fee | $79 | $178 |
| Consultation fee | $0 | $178 |
| Shipping | $0 | $178 |
| Series | Start | 6 mo | 12 mo | 18 mo | 24 mo |
|---|---|---|---|---|---|
| TRYM Health · Trimi | 0$ | 750.0$ | 1500.0$ | 2250.0$ | 3000.0$ |
| NexLife | 0$ | 834.0$ | 1668.0$ | 2502.0$ | 3336.0$ |
| Yucca Health | 0$ | 1350.0$ | 2700.0$ | 4050.0$ | 5400.0$ |
Why does 'cheapest' change meaning depending on when you ask?
A programme can be cheapest in month one, mid-table by month three when an introductory rate expires, and expensive by month eight when a dose surcharge applies. Each of those is a defensible use of the word 'cheapest', which is precisely why the word is unhelpful without a stated horizon.
This site fixes the horizon at sustained recurring cost, because the withdrawal evidence makes sustained treatment the realistic scenario. A reader whose horizon is genuinely one or two months — trialling tolerability, for instance — should weight the first-month figure instead, and the first-month calculator exists for that purpose.
How sensitive is this ranking to its own assumptions?
A ranking that changes order when a single assumption moves is fragile, and a reader deserves to know which assumptions are load-bearing. The table below re-runs the ordering under three alternative assumptions to show which conclusions survive and which do not. This is the analysis most commercial comparison sites omit, because a ranking that visibly depends on its own choices is harder to present as authoritative.
| Provider | Committed monthly | Month-to-month | Committed year | Flexible year |
|---|---|---|---|---|
| TRYM Health | $125 | $180 | $1,500 | $2,160 |
| Trimi | $125 | $235 | $1,500 | $2,820 |
| NexLife | $139 | $169 | $1,668 | $2,028 |
| Yucca Health | $225 | $258 | $2,700 | $3,096 |
| Fridays | $240 | $359 | $2,880 | $4,308 |
| Mochi Health | $278 | $278 | $3,336 | $3,336 |
| Eden | $298 | $298 | $3,576 | $3,576 |
The ordering is not stable across the two assumptions in the September 4, 2026 dataset, and that is the most important thing this table shows. On committed pricing, TRYM Health and Trimi tie at $125 per month — but both figures require a twelve-month prepayment of $1,500, and Trimi's refund policy is reported as non-refundable after intake. Month to month, NexLife's $169 is the lowest verified figure, with TRYM Health at $180, Trimi at $235 and Yucca Health at $258. Where a ranking only holds under a twelve-month commitment, the commitment is doing the work rather than the price; that is now the case at the top of this table, so this site names both bases and lets the reader choose the one that matches how they intend to pay.
What happens to this ranking when the excluded records are resolved?
22 of 29 records are currently outside the ranked set. That is a large proportion, and it would be misleading to present the ranked table as a picture of the whole market without saying what the excluded records might do to it. Each exclusion category resolves differently.
| Exclusion category | Count | Providers | How it would resolve |
|---|---|---|---|
| From Teaser | 10 | OrderlyMeds, Lavender Sky Health, Fifty 410, ShedRx / SHED, Willow, LifeMD, Found, Embody, SnagRx, bmiMD | These providers advertise a starting price. Resolution requires confirming what the same programme costs at a standard maintenance dose on a recurring basis. Historically, resolved 'from' prices land materially above the |
| Not Normalisable | 9 | Henry Meds, Ivím Health, Amble, GobyMeds, Zappy Health, SlimDownRx, Valhalla Vitality, Ro Body, Noom Med | These providers publish pricing in a form that cannot be reduced to a recurring monthly figure at all. Resolution requires a direct written quotation. |
| Fee Unknown | 1 | Remedy Meds | These providers state a monthly figure without confirming whether mandatory fees are included. Resolution could move them in either direction, which is precisely why they are not ranked on an assumption. |
| Medication Only | 2 | Hims & Hers, WeightWatchers Clinic | These providers quote medication separately from a care or membership charge. Resolution requires the sum. Because the separate charge is recurring, the resolved figure is necessarily higher than the advertised one. |
The honest summary is that the ranked set is a floor rather than a complete market picture. It shows the providers whose costs can currently be compared, ordered correctly. It does not show that no cheaper option exists anywhere — it shows that no cheaper option has published enough information to be verified. Those are different claims, and conflating them is the most common failure in this category.
What should you verify before acting on any ranking?
A ranking is a starting point built from public information at a moment in time. These checks convert it into a decision you can rely on.
- Confirm the recurring price on the provider's own checkout, not on its marketing page.
- Ask what the price becomes after any introductory period ends.
- Get a complete list of mandatory fees in writing.
- Ask what the price becomes at 10 mg and 15 mg.
- Ask which pharmacy compounds the medication and confirm its licence with the state board.
- Read the cancellation terms before prepaying for any multi-month plan.
- Check the price-verification date on this page against today's date.
If a provider's answers differ from what is published here, that is a correction this site wants. Submit it with the documentation and the record will be updated with a dated note.
What does this page cover, and what does it deliberately leave out?
This page addresses Advertised price, due today, recurring cost, fees and shipping and commitment, organised around the primary question of cheapest tirzepatide. Each of those elements is treated separately below rather than blended, because they carry different evidence weights and a reader is entitled to know which parts rest on randomised data and which rest on a captured commercial claim or a regulatory document.
| Element | Treatment here | Evidence basis |
|---|---|---|
| Advertised price | Covered on this page | Captured record |
| Due today | Covered on this page | Captured record |
| Recurring cost | Covered on this page | Captured record |
| Fees | Covered on this page | Captured record |
| Shipping and commitment | Covered on this page | Captured record |
| Individualized clinical instruction | Deliberately not covered | Belongs with each provider's own checkout |
What are the limits of what this page can tell you?
Every page on this site rests on a specific ranking methodology and its inputs, and that record has boundaries worth stating plainly rather than leaving a reader to discover them. The limitations below are specific to the material presented above.
- The evidence here describes groups, populations, or captured records — it does not describe you, and no page can substitute for each provider's own checkout.
- Figures carry the date on which they were verified. In a market where terms change frequently, an undated figure functions as a claim about the present that nobody has checked.
- Elements marked Verification Pending are genuinely unknown to this publication rather than merely omitted for brevity, and should not be inferred from surrounding content.
- Where a source conflicts with another, this site shows the conflict rather than resolving it, which means some questions are left open on purpose.
What would change the conclusion on this page?
The following would trigger a revision to this page, recorded in its change history:
- New primary evidence bearing directly on cheapest tirzepatide.
- A change to FDA labelling affecting any statement made above.
- A verified correction submitted through the corrections process and accepted on the evidence.
- A material change to a captured record, including a price, term, or regulatory status.
- Completion of a verification currently marked pending, which would replace a gap with a stated fact.
What do the technical terms on this page mean?
Definitions for the 6 technical terms this page uses, including 503A, 503B, DOI, compounded — in the specific sense used above.
| 503A | A pharmacy that compounds patient-specific preparations against individual prescriptions. It is licensed by a state board of pharmacy and is not subject to the same federal manufacturing requirements as a 503B facility. |
|---|---|
| 503B | An outsourcing facility that may compound in larger batches without individual prescriptions. It registers with the FDA and is subject to current good manufacturing practice requirements, though registration is still not product approval. |
| DOI | Digital Object Identifier. A persistent link to a specific published article that continues to resolve even if the journal reorganises its website. |
| compounded | Prepared by a pharmacy rather than manufactured under an approved application. Compounded tirzepatide is not FDA approved and has not been evaluated in any randomised trial. |
| effective monthly cost | The recurring amount actually paid each month once every mandatory fee is included. It is frequently higher than the advertised medication price, which is why this site normalises before ranking. |
| membership fee | A recurring charge separate from the medication price, common in telehealth weight programmes. It can add $40 to $80 per month and frequently reverses which provider is genuinely cheaper. |
Frequently asked questions
What is the cheapest tirzepatide provider?
Among records where mandatory-fee inclusion is confirmed, the ranking above orders them by computed recurring cost. Lower advertised prices exist but are not like-for-like.
Why is a $99 advertised price not the cheapest?
Because a separate mandatory membership can add $40-$80 monthly, making the real cost higher than a provider publishing a higher all-in figure.
Do introductory prices count in this ranking?
No. Introductory rates are excluded because they are not the recurring cost of ongoing treatment.
Is cheap compounded tirzepatide risky?
Price alone is not a quality signal in either direction. What matters is whether the pharmacy can be verified — which is unverified across this dataset.
How often do these prices change?
Frequently. Each row carries its capture date; confirm at the provider's checkout.
Change history
| Date | Change |
|---|---|
| 2026-07-22 | Page published with current dataset snapshot. |
| 2026-09-04 | Ranked set rebuilt from the 2026-09-04 dataset: NexLife's September 2026 card re-read live ($139 committed, $169 month to month); Trimi ($125 annual) and Yucca Health ($225 six-month) admitted on first-party plan tables; Embody, SnagRx and bmiMD recorded as excluded; Fridays' month-to-month figure corrected to $359; 7 of 29 records now ranked. NexLife disclosed as a commercial partner; the relationship is labelled and is not a ranking input. |
Dates change only for substantive edits, never for cosmetic changes. Corrections: corrections policy.